Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
Ju
Ji Hyeon
JH
The Catholic University of Korea, Seoul, South Korea.
Kim
Sung-Il
SI
Lee
Jun-Hee
JH
Lee
Sang-Il
SI
Yoo
Wan-Hee
WH
Choe
Jung-Yoon
JY
Chung
Seung-Hie
SH
Lee
Jisoo
J
Lee
You-Hyun
YH
Lee
Shin-Seok
SS
Yoon
Hyun-Jung
HJ
Yoon
Chong-Hyeon
CH
Kim
Ho-Youn
HY
Park
Sung-Hwan
SH
D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000208:ethnology; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D007723:Korea; D000077339:Leflunomide; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000208:ethnology; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D018501:Antirheumatic Agents; D007555:Isoxazoles; D000077339:Leflunomide